Holding(s) in Company

Dechra Pharmaceuticals PLC
14 January 2008


                                                                    

TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES


(1). Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached:

DECHRA PHARMACEUTICALS PLC


2. Reason for the notification (please state Yes/No): (   )

An acquisition or disposal of voting rights:                               (X  )

An acquisition or disposal of financial instruments which may result 
in the acquisition of shares already issued to which voting rights are 
attached:                                                                  (   )

An event changing the breakdown of voting rights:                          (   )

Other (please specify) :  SPECIAL NOTIFICATION REQUIRED BY DTR             (   )


 
3. Full name of person(s) subject to the notification obligation:

NEWTON INVESTMENT MANAGEMENT LIMITED
 

4. Full name of shareholder(s) (if different from 3.):

NEWTON INVESTMENT MANAGEMENT LIMITED
 

5. Date of the transaction and date on which the threshold is crossed or reached
if different):

11.01.08
 

6. Date on which issuer notified:

14.01.08
 

7. Threshold(s) that is/are crossed or reached:

DECREASE FROM 3.22% TO 2.31%
 

8. Notified details:

SALE OF 588,748 SHARES
 


A: Voting rights attached to shares

 
Class/type of shares            Situation previous to  
if possible using the           the Triggering         
ISIN CODE                       transaction        
                       Number of shares       Number of voting Rights 
GB0009633180           2,085,227              3.22% 


 

                     Resulting situation after the triggering transaction 
 
Class/type of shares Number of shares  Number of voting rights    % of voting rights  
if possible using                                                                 
the ISIN CODE                                                                         
                     Direct            Direct     Indirect        Direct    Indirect  
                                                  1,496,479                 2.31%

 

B: Financial Instruments

Resulting situation after the triggering transaction 

Type of     Expiration Date  Exercise/Conversion Number of voting     % of voting     
financial                    Period/ Date        rights that may be   rights          
instrument                                       acquired if the                      
                                                 instrument is                        
                                                 exercised/                           
                                                 converted.                           

 

Total (A+B)
Number of voting rights       % of voting rights 
1,496,479                     2.31%

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

NEWTON INVESTMENT MANAGEMENT HOLDS THESE SHARES AS DISCRETIONARY 
INVESTMENT MANAGERS
 


Proxy Voting:

 
10. Name of the proxy holder:


 

11. Number of voting rights proxy holder will cease to hold:


 

12. Date on which proxy holder will cease to hold voting rights:


 

13. Additional information:


 

14. Contact name:

ASIF LALANI
 

15. Contact telephone number:

020 7163 5115


 



                      This information is provided by RNS
            The company news service from the London Stock Exchange